These findings, together with our results from the analyses of xenograft tumor growth and intraperitoneal tumor spread (Figure 6), establish that the silencing of JLP with the resultant decrease in the activation of JNK signaling node inhibits tumor growth and intraperitoneal spread of ovarian xenograft tumors. This evidence concerns the gene SPAG9 and neoplasm.